For All The Latest Medical News, Health News, Research News, COVID-19 News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Cardiology News, Epigenetic News, Cancer News, Doctor News, Hospital News
Coronavirus News is a section dedicated to the new coronavirus that is causing an epidemic in China and fast spreading globally. The strain of coronavirus called Covid-19 or also commonly called the Wuhan coronavirus is genetically more potent and faster spreading than the SARS coronavirus. Currently teams are working to develop a new vaccine for this new coronavirus while other teams are trying t...
Source: COVID-19 Supplements-Flavonoids Sep 18, 2021 3 years ago
COVID-19-Supplements: As part of Thailand Medical News continued initiatives on herbs and phytochemical research for treating COVID-19 and also Long COVID, the following coverage on the usage of herbs and phytochemicals to treat COVID-19 and a health conditions arising with the novel coronavirus infection or what is termed as Long COVID or PASC (Post-acute Sequelae of COVID-19) shows the growing i...
Source: SARS-CoV-2 Variants Sep 18, 2021 3 years ago
SARS-CoV-2 Variants: French researchers in a new study have identified a new Delta sub-variant that is of concern as it not only possess the unique mutation S:E484Q found on the Kappa variant but it also has the S:T95I mutation found on the Iota variant that is associated with breakthrough infections!
Alarmingly other mutations were also found on the new Delta sub-variant phylogenetic clus...
Source:Hypertension And mRNA Vaccines Sep 18, 2021 3 years ago
A study by researchers from Lausanne University Hospital-Switzerland has found that an extremely small percentage of otherwise healthy individuals who receive the mRNA vaccines such as those by Pfizer or Moderna, run the risk of developing stage III hypertension upon vaccination.
The study findings were published in the peer reviewed journal: Hypertension (A Journal of the American Heart Associat...
UPDATED 17th October 2021:After the publication of our article on September 17th, numerous researchers responded and a team from Washington University in St. Louis, University of Illinois and Harvard University got together to conduct a detailed study which confirms that the COVID-19 vaccines does cause increased menstrual bleeding and also disrupts and causes irregular menstruation periods.
 ...
Source: SARS-CoV-2 Airborne Sep 17, 2021 3 years ago
SARS-CoV-2 Airborne: As predicted by Thailand Medical News in our earlier coverage, study findings by researchers from the University of Maryland shows that the SARS-CoV-2 coronavirus is evolving to become even better at airborne transmissions.
To date, SARS-CoV-2 epidemiology implicates airborne transmission but aerosol infectiousness and impacts of masks and variants on aerosol shedding ...
Source: COVID-19 Research Sep 17, 2021 3 years ago
COVID-19 Research: A new private study by researchers from Vanda Pharmaceuticals Inc, a global biopharmaceutical company focused on the development and commercialization of innovative therapies located in Washington DC-USA has uncovered that the chemokine receptor and the chemokine CXCR6/CXCL16 plays a key role in the in the immuno-pathogenesis of severe COVID-19.
 ...
Long COVID News: A new study by researchers from the University of Texas-Arlington shows that young and otherwise healthy adults would suffer persistent peripheral macrovascular and microvascular complications following ‘recovery’ from COVID-19.
The study was the first to investigate the persistent effects of COVID-19 on vascular function in otherwise healthy young adults.
&nbs...
Source: COVID-19-Myocarditis Sep 16, 2021 3 years ago
COVID-19 and Myocarditis: A new study by researchers from the Drug Safety Research Unit, Southampton-UK and the School of Pharmacy and Biomedical Sciences, University of Portsmouth-UK warns about the occurrences of myocarditis and pericarditis in men following mRNA-based COVID-19 vaccination. Though considered rare events, the number of cases being reported worldwide is of a concern.
The s...
COVID-19 Drugs: The phase 1a clinical trial led by researchers from the University of Liverpool-UK using the antiparasitic drug Nitazoxanide has shown potential in terms of treating the COVID-19 disease. The research team also comprised clinicians and scientist from University of Southampton-UK, University of Cambridge-UK, the Liverpool School of Tropical Medicine-UK and the Liverpool University H...
Source: COVID-19 Supplements-Quercetin Sep 15, 2021 3 years ago
COVID-19 Supplements: Since Thailand Medical News first covered a collection of studies in August 2020 showing that Quercetin could be used as adjuvant to treat COVID-19, its effectiveness has since been proven in many subsequent studies and even randomized clinical trials. https://www.thailandmedical.news/news/breaking-supplements-for-covid-19-quercetin-emerging-as-an-adjuvant-for-covid-19-treatm...
Source: New SARS-CoV-2 Variants Sep 15, 2021 3 years ago
New SARS-CoV-2 Variants: Researchers from the City University of New York, University of Missouri-School of Medicine and The New School-New York (A private university) have in a new study alarmingly come across four new unique “cryptic” lineages of the SARS-CoV-2 coronavirus ie WNY1, 2, 3, and 4, from wastewater sites. Shockingly these new variants had an assortment of mutations ...
Source: COVID-19-Innovations Sep 14, 2021 3 years ago
COVID-19 Innovations: Scientist from Ohio State University along with researchers from the Ford Research and Innovation Center-Michigan have in a new study explored the use of heat treatments to inactivate SARS-CoV-2 in passenger vehicles including cars, van and buses.
According to the study abstract, “Heat is an established method to inactivate coronaviruses, and there is utility in...
Source: Thailand Coronavirus News Sep 14, 2021 3 years ago
Thailand Coronavirus News: A very strange and confusing thing happened yesterday, local Thai health officials released data to the media saying that of those who died from COVID-19, 14.4% had already received the first dose of the COVID-19 vaccine.
Perhaps they were trying to point to the fact that a single dose of COVID-19 vaccine does not guarantee survival if infected. However various c...
Medical Alert: Yet another alarming study finding on the multitude of negative effects that the novel coronavirus has on the human host, this time from a research by scientist from Yale University School of Medicine, Icahn School of Medicine at Mount Sinai, and Iowa State University. The research findings reveals that the SARS-CoV-2 coronavirus expresses a microRNA or miRNA called vmiR-5p that is ...
Long-COVID News: Scientists from the University of Vermont-USA along with support from researchers from Duke University School of Medicine-North Carolina-USA have in a new study confirmed that the SARS-CoV-2 coronavirus has the ability able to cause damage to the DNA and telomeres of the human host. The study findings has alarming implications in terms of long term medical conditions and also help...
COVID-19 News: A new study led by Brazilian researchers from the University of São Paulo that also included scientists from the University of Campinas, Universidade do Estado do Amazonas, Universidade Federal do Amazonas, Hospital Israelita Albert Einstein and other institutions have found that acid pH enhances SARS-CoV-2 infection by up-regulating the ACE2 receptors and found that individu...
Source: A Letter To Thailand Medical News Sep 12, 2021 3 years ago
A Letter To Thailand Medical News: The world is getting crazy day by day all because of those controlling the COVID-19 narratives. I am all for vaccines but vaccines that fully work and are 100% safe. Not vaccines that cannot stop the spread of a disease. Not vaccines that allow breakthrough infections. And certainly note that vaccines that cannot stop disease severity, hospitalizations and mortal...
Source: SARS-CoV-2 Research Sep 12, 2021 3 years ago
SARS-CoV-2 Research: Chinese scientist from Shandong University in Jinan-China have discovered that the SARS-CoV-2 ORF9b proteins are able to inhibit type I and III interferon (IFN) response and production by targeting various components of various immune signaling pathways.
The study findings were published in the peer reviewed Journal of Medical Virology. https://onlinelibrar...
Source: Latest COVID-19 Research Sep 12, 2021 3 years ago
Latest COVID-19 Research: Chinese researchers from Nanjing University, Wuhan Institute of Virology, National Center of Gerontology at Beijing Hospital and the Army Engineering University of PLA have in a new breakthrough study identified 4 human host exosomal miRNAs that possess antiviral properties and are able to inhibit the SARS-CoV-2 coronavirus. Furthermore it was found that varying amounts o...
Source: COVID-19 Research Sep 11, 2021 3 years ago
COVID-19 Research: A new breakthrough study by scientist from New York University Grossman School of Medicine has found SARS-CoV-2 induced hyperactive platelets’ unique genes S1000A8 and S1000A9 causes the platelets to produce more myeloid-related proteins (MRP) 8 and 14 that contribute to increased inflammation, clotting, disease severity and longer hospital stays. The study also show...
Source: India Medical News Sep 11, 2021 3 years ago
India Medical News: India’s Prime Minister Narendra Modi on Friday (10th September 2021) chaired a high-level meeting on the COVID situation, preparations and vaccination status as the government noted high caseloads in states like Kerala and Maharashtra. A government spokesman on conditions of anonymity said that the meeting was called for urgently as there has been ‘domestic and...
Source: Mu Variant B.1.621 Sep 11, 2021 3 years ago
Mu variant: Physicians from various hospitals in Massachusetts are warning that COVID-19 patients infected with the SARS-CoV-2 Mu variant are appearing in many hospitals in the state, indicating that the Mu variant is fast spreading. They urge more close monitoring and extra vigilance as the variant could take over the Delta variant as the dominant strain in a matter of weeks.
Many ex...
Source: COVID-19 Symptoms Sep 10, 2021 3 years ago
COVID-19-Symptoms: A new study by researchers from the Laboratory of Oral Histopathology, Health Sciences Faculty, University of Brasilia-Brazil has found that dry mouth or Xerostomia is another new symptom of experienced by those with COVID-19. Dry mouth is also a more common symptom in those infected with the Delta variants according to sources not involved with the study.
The stud...
Long-COVID: The COVID-19 pandemic is an extremely dynamic event in which new and better evolving research are constantly materializing and superseding whatever we had earlier known along with the fact that there are constantly new players in the pandemic due to the variety of emerging SARS-CoV-2 variants, each with unique mutations, characteristics, pathogenesis and their own specific manner of di...
Source: Probiotics and COVID-19 Sep 09, 2021 3 years ago
Probiotics-COVID-19: A new study by Italian researchers from the University of Rome and the University of L’Aquila has found that oral bacteriotherapy involving probiotics comprising of lactic acid bacteria and bifidobacteria not only decreases the risk of respiratory failure in COVID-19 but it also decreases the risk of disease severity and also the need for hospitalization. Oral admin...
Source: Pediatric COVID-19 Sep 09, 2021 3 years ago
Pediatric COVID-19: Researchers from the Pediatric Neurology Unit at the Hadassah Medical Center-Israel and the School of Medicine at the Hebrew university of Jerusalem-Israel have in a clinical study found that seizures are a manifestation of severe SARS-CoV-2 infection in children.
The study team conducted a systematic retrospective study to identify all children who presented to the eme...
Source: Mu or B.1.621 variant Sep 08, 2021 3 years ago
New alarming study findings by Japanese researchers from the University of Tokyo, Kyoto University, Chiba University and Tokai University have shown and confirmed that convalescent and vaccine sera has little or no effect on the fast globally spreading Mu SARS-CoV-2 variants.
The study findings were published on a preprint server and are currently being peer reviewed. https://www.bio...
Source: SARS-CoV-2 Delta Variant Sep 08, 2021 3 years ago
The largest ever and detailed study led by researchers from the University of Cambridge along with scientists and experts from University College London-UK, National Centre for Disease Control-India, CSIR Institute of Genomics and Integrative Biology-India ,Imperial College London-UK,Sri Ganga Ram Hospital-India, Indraprastha Apollo Hospital-India. The Genotype to Phenotype Japan (G2P-Japan)...
IBD-COVID-19: A new study by researchers from Israel has found that patients with inflammatory bowel disease (IBD) taking tumor necrosis factor (TNF) α inhibitors will experience decreased COVID-19 vaccine efficacy.
The study findings were published on a preprint server and are currently being peer reviewed.
It is already known that IBD patients treated with immunomodulatory d...
Source: COVID-19-Nipah Virus Sep 07, 2021 3 years ago
India Medical News: Kerala, an Indian Southern state has reported an outbreak of the Nipah Virus as it is still struggling with the COVID-19 crisis due to the fast spreading Delta variant.
In the last 24 hours alone, the Indian state of Kerala recorded a total of 19,688 new COVID-19 infections and 135 COVID-19 deaths.
Health and government authorities in Kerala quickly ramping up ef...
Source: COVID-19 Research Sep 07, 2021 3 years ago
COVID-19 Research: Yet another alarming study finding has emerged from a research by scientists from the Fred Hutchinson Cancer Research Center-Seattle and the institute for Systems Biology-Seattle in which it has been found that the SARS-CoV-2 coronavirus is able to cause metabolic changes to the plasma and immune cells of the human host!
Furthermore the study findings also show that these chang...
Lambda variant: A new study by researchers from the Department of Immunology and Genomic Medicine, National Jewish Health-Denver and the Department of Immunology and Microbiology, School of Medicine, Anschutz Medical Center, University of Colorado-USA along with scientists from the State Key Laboratory of Agrobiotechnology, College of Biological Sciences, China Agriculture University, Beijing...
NeuroCOVID: New alarming study findings by researchers from the Ruđer Bošković Institute-Croatia, University of Zagreb-Croatia and the National Institute of Chemistry- have shown that the Spike proteins of the SARS-CoV-2 coronavirus have a strong biding affinity for the enzyme found in the brain called monoamine oxidases (MAO) enzymes and it is as a result of these binding and su...
Source: COVID-19 And Dysphagia Sep 06, 2021 3 years ago
COVID-19-Dysphagia: Researchers from University of Foggia-Italy have found that many hospitalized COVID-19 patients who are non-intubated tend to manifest Dysphagia or swallowing difficulties.
The study findings were published in the peer reviewed journal: European Archives of Oto-Rhino-Laryngology
https://link.springer.com/article/10.1007/s00405-021-07062-3
Dysphagia is condi...
Source: COVID-19-Pituitary Gland Sep 06, 2021 3 years ago
COVID-19-Pituitary Gland: More worrisome study findings have emerged from a research conducted by Italian neurology scientists from Università Vita-Salute San Raffaele , Milan-Italy along with support from the Pituitary Center, Departments of Medicine and Neurological Surgery, Oregon Health and Science University-U.S.A in which it has been found that the SARS-CoV-2 coronavirus is able ...
Source: COVID-19 Drugs-Fluvoxamine Sep 06, 2021 3 years ago
COVID-19 Drugs: Results from the TOGETHER multi-institutional, multi-country randomized platform clinical trials of various repurposed drugs to treat COVID-19 has shown that treatment with fluvoxamine (100mg twice daily for 10 days) among high-risk outpatients with early diagnosed COVID-19, reduced the need for extended emergency room observation or hospitalization.
The institutions ...
Source: China's COVID-19 Vaccines Sep 05, 2021 3 years ago
Doctors and medical researchers from the Eye Institute, Cleveland Clinic Abu Dhabi-UAE have reported instances of individuals experiencing various adverse ocular events as a result of having taken the China’s Sinopharm COVID-19 vaccine.
A total of 9 patients presented with ocular complaints 5.2 days after administration of the inactivated COVID-19 vaccine by Sinopharm.
The cli...
Source: COVID-19 Research Sep 05, 2021 3 years ago
COVID-19 Research: A new study by researchers from New York University Grossman School of Medicine, NYU Langone Health-USA has found that higher viral loads of the SARS-CoV-2 coronavirus in the lungs of those infected by the SARS-CoV-2 coronavirus is what is driving increased mortality risks especially in those hospitalized and requiring mechanical ventilation. The study also found that low anti-S...
COVID-19 Drugs: Researchers from the University of California-San Francisco along with support from Stanford University are exploring the use of the abortion drug Ethacridine to inhibit SARS-CoV-2 by inactivating viral particles and to assess its potential as a prophylaxis and also therapeutic agent to treat COVId-19.
Their study findings were published in the peer reviewed journal: PLOS Pathogen...
Source: COVID-19 Supplements Sep 04, 2021 3 years ago
COVID-19 Supplements: A new study by medical researchers from Canisius-Wilhelmina Hospital-Netherlands, Maastricht University-Netherlands and also involving doctors from University Hospitals Leuven-Belgium has found that Vitamin K play a critical role in preventing COVID-19 disease severity especially involving lung damage and thromboembolism.
Thailand Medical News strongly feels that these ...
Source: SARS-CoV-2 Genomic Surveillance Sep 03, 2021 3 years ago
SARS-CoV-2 Genomic Surveillance: Thailand Medical News would first like to bring up certain issues with regards to the genomic surveillance of the SARS-CoV-2 coronavirus and to highlight how badly it is being managed throughout the world.
While there has been extensive focus on understanding the amino acid mutations in the Delta variant’s Spike protein, the mutational landscape of th...
Source: Supplements For COVID-19 Sep 03, 2021 3 years ago
Supplements For COVID-19: A new study by researchers from King's College London-UK, Massachusetts General Hospital-USA, Lund University-Sweden, University College London-UK, University of Nottingham-UK and University of Southampton-UK has shown that women do benefit modestly from taking multivitamins, Omega-3 supplements and probiotics in terms of decreasing the risk of COVID-19.
Based...
Source: COVID-19 And Hyperglycaemia Sep 03, 2021 3 years ago
Researchers from the Università di Milano in Italy and the from the Nephrology Division, Boston Children’s Hospital,Harvard Medical School-USA are warning that there will be a huge surge of diabetes caseloads in individuals who had been infected with the COVID-19 disease despite being healthy prior to the SARS-CoV-2 infection.
COVID-19 patients who were otherwise healthy...
Source: COVID-19 Immunology Sep 02, 2021 3 years ago
COVID-19 Immunology: A new study by the University of Vienna-Austria has shown that early exposure of the human host’s nasopharyngeal mucosa to antiviral interferon activates epithelial cells to inhibit the SARS-CoV-2 coronavirus.
The study findings were published in the peer reviewed the Journal of Experimental Medicine (JEM).
https://rupress.org/jem/article/218/10/e...
Source: COVID-19 Research Sep 02, 2021 3 years ago
A new study led by researchers from the University of Queensland-Australia has shockingly found that unique proteins called fusogens found on the surface of the spike proteins of the SARS-CoV-2 coronavirus is able cause the fusion of neurons cells and also cause fusion between neurons and glial cells. This phenomena could possibly explain the various neurological manifestations in both COVID...
Source: BCG or bacille Calmette-Guérin vaccine and COVID-19 Sep 02, 2021 3 years ago
A new study led by researchers from the U.S. National Institute of Allergy and Infectious Diseases, NIH claims that the bacille Calmette-Guérin (BCG) vaccine could offer protection against COVID-19 disease severity and mortality based on study findings involving mice models.
According to the study team, early events in the host response to SARS-CoV-2 are thought to play a major role in det...
A new study by researchers at Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care System has alarmingly found that most ‘recovered’ COVID-19 patients including those that initially only had a mild condition of the disease upon infection will still ultimately develop kidney damage over time.
Numerous studies continue to mount indi...
Source: Physical Exercise and COVID-19 Sep 01, 2021 3 years ago
A study conducted last year by Brazilian researchers from São Paulo State University (UNESP) is once again getting revived by various research groups and a few clinical trials are expected to start soon based on those earlier significant findings.
The study team then had found that the hormone Irisin produced during exercising can prevent COVID-19 disease severity by modulating host genes....
Source: COVID-19 Pandemic Sep 01, 2021 3 years ago
More great news emerging as the once ‘model country’ that was used by many ignorant researchers and mainstream media to showcase how ‘effective’ the COVID-19 vaccines were in terms of returning life to normalcy is now facing critical times again due to the rising SARS-CoV-2 infections brought on by the wonderful Delta variant. (Certain stupid ‘experts’ had...
Source: Pulmonary Fibrosis Sep 01, 2021 3 years ago
A new breakthrough study by researchers from University of Alabama at Birmingham-USA has found that the drug Venetoclax used to treat adult patients with Chronic Lymphocytic Leukemia (CLL) could be repurposed to reverse lung fibrosis after successful mouse model drug trials.
Venetoclax, sold under the brand names Venclexta and Venclyxto, is a medication used to treat adults with chronic lymp...
Source:Long-COVID-FibroCOVID Sep 01, 2021 3 years ago
A new Italian study led by the Rizzoli Orthopedic Institute and the University of Bologna that also involved researchers from the University of Catanzaro, University of Turin, Università Campus Bio-Medico di Roma and the University of Ferrara has alarming found that there is now a growing prevalence of the medical condition known as fibromyalgia among so called recovered COVID-19 patients w...
Researchers from the Centro Nacional de Investigaciones Cardiovasculares (CNIC)-Spain and the IIS-Fundación Jiménez Díaz University Hospital-Spain have in a new clinical study discovered that metprolol- a cheap drug widely used to treat cardiovascular disease, is beneficial in treating severely ill COVID-19 patients.
Metoprolol, sold under the brand name Lopressor, amo...
Source: Controversial COVID-19 Research Aug 31, 2021 3 years ago
A new research by Brazilian researchers from the National Institute of Science and Technology for Innovation-Brazil, Oswaldo Cruz Institute, Iguaçu University and the Federal Fluminense University has found that the SARS-CoV-2 proteins binds not only to metabolites of hemoglobin like biliverdin but also to hemoglobin itself!
The study findings were published in the peer review...
Source: COVID-19 Immunology Aug 31, 2021 3 years ago
A new study by researchers from the University of Helsinki-Finland has discovered the important role that Low-density granulocytes (LDG) play in the role of COVID-19 disease outcomes.
Typically severe COVID-19 is characterized by extensive pulmonary complications, to which host immune responses are believed to play a role. As the major arm of innate immunity, neutrophils are one of the first cell...
Source: COVID-19 Research Aug 31, 2021 3 years ago
COVID-19 Research: A new study published in the peer reviewed journal: Allergy (The European Journal of Allergy and Clinical Immunology) warns that about 20% of individuals who have recovered from COVID-19 or even having received full vaccine doses will not develop immune protection against the SARS-CoV-2 coronavirus! https://onlinelibrary.wiley.com/doi/10.1111/all.15066
Accor...